Mounjaro 5 mg KwikPen 4 Doses 1 Pen

Description

Mounjaro KwikPen contains an active substance called tirzepatide and is used to treat adults with type 2 diabetes mellitus. Mounjaro reduces the level of sugar in the body only when the levels of sugar are high. Mounjaro is also used to treat adults with obesity or overweight (with BMI of at least 27 kg/m2). Mounjaro influences appetite regulation, which may help you eat less food and reduce your body weight. In type 2 diabetes, Mounjaro is used: On its own when you can’t take metformin (another diabetes medicine). With other medicines for diabetes when they are not enough to control your blood sugar levels. These other medicines may be medicines taken by mouth and/or insulin given by injection. How to use The starting dose is 2.5 mg once a week for four weeks. After four weeks, your doctor will increase your dose to 5 mg once a week. Your doctor may increase your dose by 2.5 mg to 7.5 mg, 10 mg, 12.5 mg or 15 mg once a week if you need to. In each case, your doctor will ask you to stay on a certain dose for at least 4 weeks before taking a higher dose. How to inject Monjaro Quick Pen Mounjaro is injected under the skin (subcutaneously) in the stomach area (abdomen), upper leg (thigh), or upper arm. You may need help from someone else if you want to inject into your upper arm. If you like, you can use the same area of ​​your body every week. But be sure to choose a different injection site within that area. If you also inject insulin, choose a different site to inject it. Warnings and precautions Talk to your doctor, nurse or pharmacist before using Mounjaro if: You have serious problems digesting food or food staying in your stomach longer than usual (including severe gastroparesis). I have had pancreatitis in the past (inflammation of the pancreas that can cause severe, persistent pain in the stomach and back). You have an eye problem (diabetic retinopathy or macular edema). You are using a sulfonylurea (another diabetes medicine) or insulin for your diabetes, because you may have a risk of low blood sugar (hypoglycemia). Your doctor may need to change your dose of these other medicines to reduce this risk. You have gallbladder problems. Gallbladder problems have occurred in some people who take Mounjaro. Tell your doctor right away if you develop symptoms of gallbladder problems which may include pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), clay-colored stools. Side Effects Common (may affect up to 1 in 10 people) Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with both metformin and a sodium-glucose co‑transporter 2 inhibitor (another diabetes medicine) Allergic reaction (hypersensitivity) (e.g., rash, itching, and eczema) Dizziness observed in patients treated for weight management. Low blood pressure observed in patients treated for weight management Stomach (abdominal) pain Being sick (vomiting) – this usually goes away over time (observed in patients treated for type 2 diabetes) Storage Information Store in the refrigerator (2°C - 8°C). Do not freeze. If the pen is frozen, do not use it. Store protected from light. Monjaro Quick Pen can be stored without refrigeration at a temperature not exceeding 30°C after your first injection. For up to 30 days. Drug Interactions Before using Mounjaro, tell your doctor, pharmacist or nurse if you are taking medicines to treat diabetes including insulin or sulphonylureas which can increase the risk of low blood sugar. Talk to your doctor, pharmacist or nurse about low blood sugar levels and how to manage them. Ingredients Tirzepatide Specifications Mounjaro is a clear, colourless to slightly yellow solution for injection in a pre-filled QuickPen pen.